SCHEMBL24210245

SCHEMBL24210245

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccc(-n5c6ccccc6c6ccc7c8ccc9c%10ccccc%10n(-c%10ccccc%10)c9c8sc7c65)cc4)n3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ ATM Q13315 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ AVPR1A P37288 1/20 0.35
▸ KMT2A Q03164 4/20 0.35
▸ IL1R1 P14778 1/20 0.35
▸ HDAC4 P56524 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ HTT P42858 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ ABCG2 Q9UNQ0 1/20 0.34
▸ MAPK1 P28482 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ESR2 Q92731 1/20 0.32
▸ RXRA P19793 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24210021 1.00 L3MBTL1 (0.42) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210243 0.99 L3MBTL1 (0.44) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210148 0.99 L3MBTL1 (0.40) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210055 0.99 L3MBTL1 (0.40) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210042 0.99 L3MBTL1 (0.40) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210135 0.95 L3MBTL1 (0.41) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24209959 0.95 L3MBTL1 (0.37) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24210011 0.95 L3MBTL1 (0.41) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24209992 0.95 L3MBTL1 (0.37) L3MBTL1ATMKDM4EAVPR1AKMT2A
SCHEMBL24209960 0.95 L3MBTL1 (0.37) L3MBTL1ATMKDM4EAVPR1AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220020933-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020933-A1 COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OCIAD2, OCIAD1, OXER1 L3MBTL1 4715/4885ATM 3631/4885KDM4E 4378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback